Hansoh Pharmaceutical Group, a Chinese drug developer that counts Hillhouse Capital and Boyu Capital among its investors, has raised HK$7.86 billion ($1 billion) through a Hong Kong IPO.
It is the 11th offering in the territory by a PE-backed Chinese healthcare company since the start of last year and the fourth of 2019. While the majority have been zero-revenue biotech players taking...
Technology disruption and short-term policy changes are the two key challenges facing investors in the energy sector, industry participants told the AVCJ Forum.
Singapore-based Keppel Corporation has agreed to buy a 50% interest in Pierfront Capital, an alternative credit investment fund manager controlled by Temasek Holdings.
Pavilion Capital and Gobi Partners had co-led an $18 million Series B round for Indonesia’s Travelio, an Airbnb-style home rentals start-up.
OneConnect Financial Technology, an affiliate of China’s Ping An Insurance backed by the likes of IDG Capital, SBI Group, and SoftBank Vision Fund, has filed to list in the US.